Interim analyses (IA) of the giredestrant (G), G + abemaciclib (A), and G + ribociclib (R) arms in MORPHEUS Breast Cancer (BC): A phase I/II study of G treatment (tx) combinations in patients (pts) with estrogen receptor-positive, HER2-negative locally advanced/metastatic BC (ER+, HER2– LA/mBC)

Bibliographic Details
Published in:	Journal of Clinical Oncology Vol. 41; pp. 1061 - 1062
Main Authors:	Oliveira, Mafalda, Sonnenblick, Amir, Rugo, Hope S., Jung, Kyung Hae, Yam, Einav Gal, Hurvitz, Sara A., Hernando, Cristina, Im, Seock-Ah, Breton, Vanessa, Collier, Ann, Schwab, Richard B., Zhu, Jing, Sohn, Joohyuk
Format:	Journal Article
Published:	American Society of Clinical Oncology 2023 Supplement 16
Online Access:	View this record in EBSCOhost